# Ajmaline Utilization in the Diagnosis and Treatment of Cardiac Arrhythmias

> **NCT00702117** · PHASE4 · COMPLETED · sponsor: **Hospital Clinic of Barcelona** · enrollment: 123 (actual)

## Conditions studied

- Atrial Fibrillation
- Tachycardia, Ventricular
- Brugada Syndrome

## Interventions

- **DRUG:** flecainide
- **DRUG:** ajmaline
- **DRUG:** procainamide

## Key facts

- **NCT ID:** NCT00702117
- **Lead sponsor:** Hospital Clinic of Barcelona
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 123 (ACTUAL)
- **Last updated:** 2010-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00702117

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00702117, "Ajmaline Utilization in the Diagnosis and Treatment of Cardiac Arrhythmias". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00702117. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*